Tata 1mg’s operating revenue jumped 2.6X to INR 1,627 Cr in FY23 from INR 627 Cr in FY22
Tata 1mg reported a total expenditure of INR 2,893.6 Cr in FY23, a 147% jump from INR 1,171 Cr in FY22
On a unit level, the startup spent INR 1.7 to earn every INR 1 from operations
Tata Digital-backed epharmacy Tata 1mg’s net loss surged 2.3X to INR 1,254.8 Cr in the financial year 2022-23 (FY23) from INR 526 Cr in FY22.
The startup, which entered the coveted unicorn club last year, also saw its operating revenue jump 2.6X to INR 1,627 Cr in FY23 from INR 627 Cr in the previous fiscal year. The startup generates revenue by primarily selling online medicine and conducting lab tests.
Total revenue, including other income, stood at INR 1,633.9 Cr in the financial year under review as compared to INR 644.8 Cr in FY22.
On the expenses font, the startup saw a 2.4X increase in FY23. Total expenditure stood at INR 2,893.6 Cr in FY23, a 147% jump from…